Overview
Allogeneic stem cell transplantation with a focus on the use of umbilical cord blood grafts; Allogenic stem cell transplantation for Sickle Cell Disease; Prevention of acute and chronic graft versus host disease; Improving immune recovery following alternative donor stem cell transplantation using donor graft manipulation.
Current Appointments & Affiliations
Professor of Medicine
·
2016 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
Member of the Duke Cancer Institute
·
2003 - Present
Duke Cancer Institute,
Institutes and Centers
Affiliate of the Duke Regeneration Center
·
2021 - Present
Duke Regeneration Center,
Basic Science Departments
Recent Publications
Sociodemographic factors and timing of allogeneic hematopoietic stem cell transplantation in myeloproliferative neoplasms.
Journal Article Bone Marrow Transplant · April 12, 2026 Full text Link to item CiteImpact of donor age on cognitive recovery in allogenic hematopoietic stem cell transplant patients with mild cognitive impairment.
Journal Article Bone Marrow Transplant · April 4, 2026 Full text Link to item CiteRecent Grants
Hematopoietic Cell Transplant and Gene Therapy for Non-Malignant Blood Disorders Biobank Resource (the `HOPE Resource')
Clinical TrialPrincipal Investigator · Awarded by National Marrow Donor Program · 2026 - 2031Blood and Marrow Transplant Clinical Trials Network
Clinical TrialPrincipal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2001 - 2031Deciphera DCC-3014-02-001: A Phase 2, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, PK, and Efficacy of Vimseltinib in Adults With Active Chronic GVHD After Failure of Prior Systemic Therapy
Clinical TrialPrincipal Investigator · Awarded by Deciphera Pharmaceuticals, LLC · 2025 - 2030View All Grants
Education
Rush University ·
1992
M.D.